Results 181 to 190 of about 1,912,136 (307)
When Positron Emission Tomography (PET) Is Misleading: Ion™ Robotic Bronchoscopy Identifies Organizing Pneumonia and Unmasks a Rare Pulmonary Granular Cell Tumor. [PDF]
Mahmood T +3 more
europepmc +1 more source
Early Feasibility of Registration of Micro‐PET/CT Scans to Annotated 3D Specimen Models
ABSTRACT Background Intraoperative 18F‐fluorodeoxyglucose (18F‐FDG) micro‐positron emission tomography/computed tomography (micro‐PET/CT) is an emerging modality for margin assessment. Prior to clinical use, micro‐PET/CT margin distances must be correlated with gold‐standard histopathology.
Joaquin Austerlitz +13 more
wiley +1 more source
ABSTRACT Background The AJCC 8th edition distinguishes p16‐positive oropharyngeal head and neck carcinoma of unknown primary (HNCUP) due to its superior prognosis. However, standardized radiation volume guidelines are lacking. This study evaluates the safety of p16‐guided mucosal volume reduction.
Philippe Harris +16 more
wiley +1 more source
Evaluation of treatment planning feasibility of a positron emission tomography (PET)-Linac system for spine stereotactic body radiotherapy (SBRT). [PDF]
Zhang H +8 more
europepmc +1 more source
ABSTRACT Background Neoadjuvant immunotherapy is an emerging treatment for patients with head and neck cancer. Given the heterogeneity of response, novel methods of intraoperative tumor and margin assessment warrant investigation. Methods A 55‐year‐old male presented with a cT3N2c supraglottic squamous cell carcinoma with a combined positive score of 5.
Joaquin Austerlitz +7 more
wiley +1 more source
Design of a Mobile and Electromagnetic Emissions-Compliant Brain Positron Emission Tomography (PET) Scanner. [PDF]
Fuentes C +10 more
europepmc +1 more source
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting. [PDF]
Zheng S +22 more
europepmc +1 more source
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır +32 more
wiley +1 more source
Role of Positron Emission Tomography (PET) in the Diagnosis of Musculoskeletal Disorders. [PDF]
Vaishya R +4 more
europepmc +1 more source
ABSTRACT Whether combining pretreatment plasma Epstein–Barr virus DNA (EBV‐DNA) with 18F‐FDG PET/CT‐derived total lesion glycolysis (TLG) improves prognostic stratification in nonmetastatic nasopharyngeal carcinoma (NPC) is unclear, particularly in nonendemic populations.
Mehmet Çağrı Duymaz +7 more
wiley +1 more source

